New hope for older leukemia patients: trial tests drug combo to extend life
Disease control
Recruiting now
This study is testing if adding an experimental drug called cusatuzumab to a standard two-drug treatment helps people with newly diagnosed acute myeloid leukemia (AML) live longer. It is for adults who are not healthy enough for strong chemotherapy. About 120 participants will be…
Phase: PHASE2 • Sponsor: OncoVerity, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC